CLINICAL_TRIALS
trial_result
· 2012-02-20
Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris [Phase 2]
Summary
Dow Pharmaceutical Sciences completed a Phase 2 study evaluating the safety and efficacy of IDP-107 in patients with acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dow Pharmaceutical Sciences | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED